A meta-analysis and systematic review of the effectiveness of vaccination interventions against Theileria parva.
Abstract
Vaccination is now considered central to managing Theileria parva parasite infections. This meta-analysis and systematic review evaluated the vaccine efficacy and effectiveness in bovine theileriosis management to date. Eighty reports, including 40 randomized controlled trials (laboratory and/or experimental and field) which tested interventions to eliminate the impact of T. parva up to June 2026, were eligible for analysis. The PRISMA search strategy was employed to gather evidence, and the ROB-2 and ROBINS-E tools were used to assess the quality of included studies. Forty studies comprising 3961 cattle were included in the meta-analysis. The cattle population had a median control size of 8 (IQR=13.5) and a median vaccinated size of 16.5 (IQR=24.25). Heterogeneity yielded an I² statistic of 97.2%, which indicated that variability in protective efficacy was attributable to genuine differences among studies. The cluster plot indicated some risk of publication bias suggesting an under-representation of low efficacy studies. The overall effect size of the vaccine intervention indicated a positive effect of 51.3% on protective efficacy. Subgroup analysis indicated that live sporozoite vaccines achieved the highest field mean protective efficacy of 87% with induction of T-cell and B-cell immune responses. However, carrier status remains a limitation, increasing the risk of breakthrough strains. Nucleic acid-based vaccines demonstrated high immunogenicity that requires translation into field protection. The lack of a standardised trial reporting design underscores the need for minimum information for veterinary vaccine trials (MIVV) to enhance future progress in veterinary vaccine development programs.